Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $95,460 - $187,710
1,500 Added 41.67%
5,100 $340,000
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $364,356 - $599,796
3,600 New
3,600 $427,000
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $347,550 - $522,150
5,000 New
5,000 $497,000
Q2 2023

Aug 14, 2023

SELL
$118.5 - $160.53 $1.53 Million - $2.07 Million
-12,900 Reduced 36.44%
22,500 $2.73 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $40,698 - $59,106
300 Added 0.85%
35,400 $5.44 Million
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $2.55 Million - $4.52 Million
-21,500 Reduced 37.99%
35,100 $6.3 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $2.6 Million - $4.27 Million
-22,000 Reduced 27.99%
56,600 $6.7 Million
Q2 2022

Aug 17, 2022

BUY
$117.13 - $176.59 $3.4 Million - $5.12 Million
29,000 Added 58.47%
78,600 $11.2 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $3.16 Million - $5.88 Million
-25,000 Reduced 33.51%
49,600 $8.54 Million
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $15.5 Million - $25.4 Million
68,830 Added 1192.89%
74,600 $18.9 Million
Q3 2021

Nov 15, 2021

SELL
$221.9 - $484.47 $15.5 Million - $33.9 Million
-70,030 Reduced 92.39%
5,770 $2.22 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $1.75 Million - $3.17 Million
13,500 Added 21.67%
75,800 $17.8 Million
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $6.8 Million - $11.6 Million
62,300 New
62,300 $8.16 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.